Virtu KCG Holdings’s Meridian Bioscience Inc VIVO Stock Holding History

Virtu KCG Holdings’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-13,061	Closed	-$180K	–	3645
2017 Q1	$180K	Sell	13,061 -1,127	-8%	-$15.8K	0.01%	2486
2016 Q4	$251K	Buy	14,188 +1,875	+15%	+$32.9K	0.01%	2324
2016 Q3	$238K	Buy	12,313 +420	+4%	+$8.22K	0.01%	2185
2016 Q2	$232K	Buy	+11,893	New	+$233K	﹤0.01%	2172
2016 Q1	–	Sell	-13,328	Closed	-$273K	–	3861
2015 Q4	$273K	Buy	+13,328	New	+$256K	﹤0.01%	2280

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Virtu KCG Holdings's VIVO Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Meridian Bioscience Inc (VIVO) in Q2 2017, closing a stake of 13,061 shares — an estimated $180K sold.

Virtu KCG Holdings first reported a position in VIVO in Q4 2015 and held it in 5 quarters. The position peaked at $273K in Q4 2015. 170 funds tracked by Wall St. Rank hold VIVO as of Q2 2017.

Virtu KCG Holdings reported no remaining Meridian Bioscience Inc position as of Q2 2017 after selling out during the quarter.
Virtu KCG Holdings sold 13,061 Meridian Bioscience Inc shares in Q2 2017, an estimated $180K.
Virtu KCG Holdings first reported a position in Meridian Bioscience Inc in Q4 2015 and held it in 5 quarters.
Virtu KCG Holdings's Meridian Bioscience Inc position peaked at $273K in Q4 2015.
170 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.